Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Kanjinti“
Suchtreffer
Begriffe & Kennungen
Kanjinti
Eintrag öffnenKanjinti · 4.1 Therapeutic indications · 1
Eintrag öffnenKanjinti · 4.3 Contraindications · 1
Eintrag öffnenKanjinti · 4.3 · • Hypersensitivity to trastuzumab, murine proteins, or to any of the excipients listed in section 6.1. • Sever
Eintrag öffnenKanjinti · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenKanjinti · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenKanjinti · 4.5 · 9 women with HER2 positive MBC indicates that individual and mean trastuzumab trough serum concentrations vari
Eintrag öffnenKanjinti · 4.5 · By comparison of simulated serum trastuzumab concentrations after trastuzumab monotherapy (4 mg/kg loading/2 m
Eintrag öffnenKanjinti · 4.5 · Comparison of PK results from two Phase II studies (BO15935 and M77004) and one Phase III study (H0648g) in wh
Eintrag öffnenKanjinti · 4.5 · Data from study JP16003, a single-arm study of trastuzumab (4 mg/kg intravenous loading dose and 2 mg/kg intra
Eintrag öffnenKanjinti · 4.5 · Effect of antineoplastic agents on trastuzumab pharmacokinetics
Eintrag öffnenKanjinti · 4.5 · Effect of trastuzumab on the pharmacokinetics of other antineoplastic agents
Eintrag öffnenKanjinti · 4.5 · No formal drug interaction studies have been performed. Clinically significant interactions between trastuzuma
Eintrag öffnenKanjinti · 4.5 · Pharmacokinetic data from Study H4613g/GO01305 in patients with metastatic or locally advanced inoperable HER2
Eintrag öffnenKanjinti · 4.5 · Pharmacokinetic data from Study H4613g/GO01305 suggested that carboplatin had no impact on the PK of trastuzum
Eintrag öffnenKanjinti · 4.5 · Pharmacokinetic data from studies BO15935 and M77004 in women with HER2 positive MBC suggested that exposure t
Eintrag öffnenKanjinti · 4.5 · The administration of concomitant anastrozole did not appear to influence the pharmacokinetics of trastuzumab.
Eintrag öffnenKanjinti · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenKanjinti · 4.8 Undesirable effects · 1
Eintrag öffnenKanjinti · 4.8 · 11 System organ class Adverse reaction Frequency Immune system disorders Hypersensitivity Common + Anaphylacti
Eintrag öffnen